SVA Sinovac Biotech, Ltd.

Sinovac Biotech Ltd is a biopharmaceutical company engaged in research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases.

As of 07/02/2020     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  Common stocks
Category3:  Small cap
GICS sector:  Health Care
Industry:  Biotechnology
Index country:  China
Country of incorporation:  
IPO date:  12/31/1969
Outstanding shares:  99,294,743
Average volume:  0
Market cap:   $642,436,987
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    P8696W104
Sedol:      2384520
Valuation   (See tab for details)
PE ratio:   6.16
PB ratio:   2.40
PS ratio:   0.00
Return on equity:   0.00%
Net income %:   0.00%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy